Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-01-18
2009-08-04
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S524000
Reexamination Certificate
active
07569562
ABSTRACT:
The invention provides N-substituted heterocyclic-sulfonamides for use in treating or preventing cognitive disorders, such as Alzheimer's Disease.Compounds of particular interest are defined by Formula (I), wherein R1, R2, Z and n are as described in the specification. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders using compounds of Formula (I).
REFERENCES:
patent: 7253158 (2007-08-01), Galley et al.
patent: 2002/0151546 (2002-10-01), Stranix et al.
patent: WO 00/50391 (2000-08-01), None
patent: WO 02/057252 (2002-07-01), None
patent: WO 2004/072034 (2004-08-01), None
patent: WO 2006/005486 (2006-01-01), None
Elan Pharmaceuticals Inc.
Kifle Bruck
McDonnell Boehnen & Hulbert & Berghoff LLP
LandOfFree
N-substituted heterocyclic sulfonamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted heterocyclic sulfonamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted heterocyclic sulfonamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4115044